Search

23 Oct 2020: Cambridge Enterprise sister organisation CIC has made an investment in Gyroscope Therapeutics, an ophthalmology company developing genetically defined therapies for eye diseases.

24 Nov 2020: Information about Data Protection, Freedom of Information, and guidance on Records Management related to both Acts.

23 Oct 2020: The patterned anvils technology removes many of the difficulties associated with achieving repeatable electrical measurements under high pressure.

23 Oct 2020: Cambridge Enterprise and its Cambridge Enterprise Fund, have invested £500k in Polypharmakos Limited, a spin-out from RGB Kew and Cambridge.

23 Oct 2020: Porous films are being developed into robust, self-cleaning antireflective coatings for use on both plastic and glass. Read more here.

23 Oct 2020: Cambridge Enterprise has joined in a £14 million funding round into ApcinteX Limited, a University spin-out developing a new therapy for haemophilia.

23 Oct 2020: Instead of pigments, these ‘polymer opals’ get their colour from their internal structure , resulting in pure colour which does not run or fade.

23 Oct 2020: The collaborative venture among three world-leading UK universities and three pharmaceutical companies has invested in its first drug discovery programmes.

23 Oct 2020: Designer piercings use self-assembling DNA building blocks to build artificial gateways through cell membranes. Read more here.

23 Oct 2020: One of the most frequently cited reasons for the success or failure of a venture is the effective formation and development of teams. Read more here.

23 Oct 2020: A fast and comprehensive method for looking at stem cells and determining the function of genes could greatly improve our understanding of disease.

23 Oct 2020: NICE has approved an MS drug developed by University of Cambridge researchers; welcomed by Cambridge researchers and by the MS Society. Read more here.

23 Oct 2020: PhoreMost has entered into an alliance with The Wistar Institute to identify and de-orphan novel targets in cancer, aging and the immune system. Read more.

23 Oct 2020: A new fuel cell electrolyte material has been developed by a University of Cambridge team.

23 Oct 2020: Sapientia is an analysis platform that allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. Read more.

23 Oct 2020: This year’s UK-wide Discovering Start-Ups competition is organised by Cambridge Wireless and Silicon South West. Read more here.

23 Oct 2020: ams has signed an agreement to acquire Cambridge CCMOSS Sensors, technology leader in micro hotplate structures. Read more here.

23 Oct 2020: Two revolutionary treatments which could alleviate pain in people with hypersensitivity to heat are being developed by University of Cambridge researchers.

23 Oct 2020: The technique, developed by Lumora, presents a viable alternative to Polymerase Chain Reaction to improve molecular diagnostics. Read more here.

23 Oct 2020: The programme was designed to test the ability of Horizon’s GENESIS rAAV gene-editing platform to generate human isogenic cell lines. Read more here.